We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.9B
2
NVRO
NEVRO CORP.
NVRO
+$76.5M
3
KBR icon
KBR
KBR
+$44.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.1M
5
BMRG.U
B. Riley Principal Merger Corp. II Units, each consisting of one share of Class A common stock and o
BMRG.U
+$9.88M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$46.4M
2
PHYS icon
Sprott Physical Gold
PHYS
+$21M
3
SPPP
Sprott Physical Platinum and Palladium Trust
SPPP
+$11.4M
4
HHHHW
Wealthbridge Acquisition Limited Warrants
HHHHW
+$10.2M
5
JIH
Juniper Industrial Holdings, Inc.
JIH
+$8.97M

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCG icon
351
CALL
PG&E
PCG
$38.4B
$1.09M 0.07%
+1,231
New +$13.4K
THBRU
352
DELISTED
Thunder Bridge Acquisition II, Ltd. Units
THBRU
$1.09M 0.07%
103,684
-2,216
-2% -$23.1K
ABBV icon
353
AbbVie
ABBV
$433B
$1.09M 0.07%
11,074
+3,422
+45% +$301K
KDNY
354
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.09M 0.07%
94,045
-5,526
-6% -$76.2K
TRNE.U
355
DELISTED
Trine Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of
TRNE.U
$1.09M 0.07%
103,924
-21,535
-17% -$225K
AIV
356
Aimco
AIV
$387M
$1.08M 0.07%
216,256
-153,319
-41% -$760K
GOOGL icon
357
Alphabet (Google) Class A
GOOGL
$4.57T
$1.08M 0.07%
15,280
-8,980
-37% -$605K
TOTAW
358
DELISTED
Tottenham Acquisition I Limited Warrant
TOTAW
$1.08M 0.07%
100,000
– –
CHMA
359
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.07M 0.07%
199,642
-90,190
-31% -$497K
JBGS
360
JBG SMITH
JBGS
$829M
$1.07M 0.07%
36,300
-36,200
-50% -$1.12M
AMD icon
361
Advanced Micro Devices
AMD
$790B
$1.06M 0.07%
20,150
-59,836
-75% -$3.17M
CMCSA icon
362
Comcast
CMCSA
$87.2B
$1.06M 0.07%
27,189
+21,249
+358% +$809K
CRBP icon
363
CALL
Corbus Pharmaceuticals
CRBP
$165M
$1.06M 0.07%
+42
New +$8.49K
DOC icon
364
Healthpeak Properties
DOC
$14.9B
$1.04M 0.07%
+37,639
New +$961K
FPAC.WS
365
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
$1.03M 0.07%
100,894
+8,204
+9% +$4.8K
SABR icon
366
Sabre
SABR
$779M
$1.03M 0.07%
127,851
+106,351
+495% +$754K
SRC
367
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$1.03M 0.07%
+29,455
New +$892K
NKLAW
368
DELISTED
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
$1.02M 0.07%
+15,162
New +$433K
ASUR icon
369
Asure Software
ASUR
$253M
$1.01M 0.07%
157,531
-32,197
-17% -$201K
BSX icon
370
Boston Scientific
BSX
$70.2B
$1.01M 0.07%
28,847
+2,536
+10% +$91.3K
WYNN icon
371
Wynn Resorts
WYNN
$10.2B
$1.01M 0.07%
+13,581
New +$1.09M
SAGE
372
DELISTED
Sage Therapeutics
SAGE
$1.01M 0.07%
24,209
+3,096
+15% +$112K
FLWS icon
373
1-800-Flowers.com
FLWS
$269M
$1M 0.07%
+50,180
New +$989K
ENTA icon
374
Enanta Pharmaceuticals
ENTA
$377M
$1M 0.07%
20,000
-4,000
-17% -$207K
MCS icon
375
Marcus Corp
MCS
$946M
$1M 0.07%
75,648
+2,176
+3% +$29.2K
13 14
15
16 17

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.